Correction to Lancet Oncol 2017; 18: e143-52
- PMID: 31044717
- DOI: 10.1016/S1470-2045(19)30240-2
Correction to Lancet Oncol 2017; 18: e143-52
Erratum for
-
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics.Lancet Oncol. 2017 Mar;18(3):e143-e152. doi: 10.1016/S1470-2045(17)30074-8. Epub 2017 Mar 2. Lancet Oncol. 2017. PMID: 28271869 Free PMC article. Review.
Publication types
LinkOut - more resources
Full Text Sources
